{"chebi_id":"50659","chebi_name":"dronedarone","chebi_synonyms":["SR 33589B","N-[2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide","N-(2-butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide","N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide","SR 33589","Multaq"],"diffprof_id_observed":["MTBLS2871_0002_00000009","MTBLS3963_0001_00000001"],"diffprof_id_var_observed":["MTBLS2871_0002_00000009"],"inchikey":"ZQTNQVWKHCQYLQ-UHFFFAOYSA-N","inn_name":"dronedarone","iupac_name":"<em>N</em>-[2-butyl-3-{4-[3-(dibutylamino)propoxy]benzoyl}-1-benzofuran-5-yl]methanesulfonamide","num_study_observed":2,"reactome_ids":["R-HSA-397014","R-HSA-5576890","R-HSA-5576891"],"reactome_names":["Muscle contraction","Phase 3 - rapid repolarisation","Cardiac conduction"],"study_id_observed":["MTBLS2871","MTBLS3963"],"study_id_var_observed":["MTBLS2871"],"synonym_name":"<em>N</em>-(2-butyl-3-(<em>p</em>-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide"}